Personalized Medicine on Muscinous Ovarian Cancer
Keywords:
ovarian cancer, ovarian, muscinousAbstract
Ovarian cancer (OC), ranking third among gynecological cancers, poses a significant health concern with the worst prognosis and highest mortality rate. The global incidence, as per 2018 data, reached 295,414 cases, constituting 3.4% of women's cancer cases. The prevalence has notably risen in Asian countries, including Singapore and Indonesia. This report highlights two cases from Dr. M. Djamil, emphasizing the importance of personalized medicine (PM) in treating OC. PM, leveraging genomic information, aids in tailoring treatments for individual patients. The standard treatment involves cytoreductive surgical debulking and platinum-based chemotherapy. Notably, PM has shown promise in addressing specific genetic mutations, such as BRCA1 and BRCA2, prevalent in breast and ovarian tumors, enabling more targeted therapeutic approaches and enhancing treatment outcomes.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Effendy Fila, Antonius Puja Agung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aCreative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.